Skip to: Content
Skip to: Site Navigation
Skip to: Search

October 7, 2008 1:28:13 AM CDT


Stories related to: Novartis AG

Stories

3 Stories

  • May 2008
    • Bone Drug Reduces Breast Cancer Relapse

      Bone Drug Reduces Breast Cancer Relapse

      (Newser) - A drug designed to protect cancer patients' bones also renders breast cancer relapses less likely, a new study says. Funded in part by the drug's maker, Novartis, researchers found that even two injections of Zometa a year cut tumor recurrence by 35% in more than 1,800 pre-menopausal women. More »

      Tags

      breast cancer   scientific study   osteoporosis   Novartis AG   bone cancer   off label drug use

  • March 2008
    • Drug Therapy Cuts Risk of Breast Cancer Relapse

      Drug Therapy Cuts Risk of Breast Cancer Relapse

      (Newser) - New research shows that women can cut the risk of breast cancer recurring years later by taking certain drugs, the Washington Post reports. Studies show that the drugs, known as aromatase inhibitors, sharply reduced the risk of cancer's return after women had finished their regimen of the widely used tamoxifen. The findings could dramatically change the treatments breast cancer survivors are given. More »

      Tags

      cancer   drugs   breast cancer   cancer research   estrogen   Novartis AG

  • January 2008
    • Beefed-Up R&D Slows Drug Approval

      Beefed-Up R&D Slows Drug Approval

      (Newser) - The FDA approved only 19 new drugs in 2007, the lowest total in 24 years. Bloomberg takes a look at the reasons. Some drug companies accuse the FDA of setting the bar higher for drug approvals, a charge the agency denies. Many, however, say the issue lies with big pharma devoting more attention to developing existing products than to creating new drugs. More »

      Tags

      FDA   GlaxoSmithKline   drug safety   Novartis AG

3 Stories

Today's Most Popular

Loading...

Premium Articles from HighBeam

Find more articles like this

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »